Abstract
Sentinel surveillance surveys combined with epidemiological/demographic models have been used in monitoring trends in mortality due to HIV in South Africa as in most other countries. The potential biases in such surveys have been highlighted in recent studies. South Africas HIV prevalence (29.5% among pregnant women attending antenatal clinics in 2004) is one of the highest in the world. National HIV prevalence from population-based survey has been carried out twice in South Africa, but is of limited use as a surveillance system independent of antenatal data. The use of vital registration in monitoring HIV related mortality has been largely unexplored. This study utilises data on registered deaths for the period 1997-2001 to estimate trends in mortality and TB/HIV related death rates in South Africa. The analysis utilizes the Growth Balance method to estimate the completeness of the death records from the registration system, and hence an adjustment factor for the registered deaths including TB/HIV related deaths in the period. The results indicate that coverage of registration of deaths in South Africa has increased over time but the completeness of registration of female deaths lags behind completeness of registration of male deaths. The absolute number of deaths is estimated to have increased from about 400,000 in 1997 to about 565,000 in 2002. Crude HIV related plus TB-AIDS death rate is estimated to have increased from about 9.6 per 10,000 in 1997 to about 19.1 per 10,000 in 2002. The increase in the number of deaths could not be attributed to population growth.
Keywords: Mortality, TB, HIV, Vital Registration, South Africa
Current HIV Research
Title: Estimation of Mortality from Vital Registrations in South Africa
Volume: 4 Issue: 4
Author(s): Eric O. Udjo
Affiliation:
Keywords: Mortality, TB, HIV, Vital Registration, South Africa
Abstract: Sentinel surveillance surveys combined with epidemiological/demographic models have been used in monitoring trends in mortality due to HIV in South Africa as in most other countries. The potential biases in such surveys have been highlighted in recent studies. South Africas HIV prevalence (29.5% among pregnant women attending antenatal clinics in 2004) is one of the highest in the world. National HIV prevalence from population-based survey has been carried out twice in South Africa, but is of limited use as a surveillance system independent of antenatal data. The use of vital registration in monitoring HIV related mortality has been largely unexplored. This study utilises data on registered deaths for the period 1997-2001 to estimate trends in mortality and TB/HIV related death rates in South Africa. The analysis utilizes the Growth Balance method to estimate the completeness of the death records from the registration system, and hence an adjustment factor for the registered deaths including TB/HIV related deaths in the period. The results indicate that coverage of registration of deaths in South Africa has increased over time but the completeness of registration of female deaths lags behind completeness of registration of male deaths. The absolute number of deaths is estimated to have increased from about 400,000 in 1997 to about 565,000 in 2002. Crude HIV related plus TB-AIDS death rate is estimated to have increased from about 9.6 per 10,000 in 1997 to about 19.1 per 10,000 in 2002. The increase in the number of deaths could not be attributed to population growth.
Export Options
About this article
Cite this article as:
Udjo O. Eric, Estimation of Mortality from Vital Registrations in South Africa, Current HIV Research 2006; 4 (4) . https://dx.doi.org/10.2174/157016206778560054
DOI https://dx.doi.org/10.2174/157016206778560054 |
Print ISSN 1570-162X |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4251 |
Call for Papers in Thematic Issues
HIV Vaccine Development.
The development of a safe and effective vaccine that impedes HIV-1 transmission and/or limits the severity of infection remains a public health priority. The HIV-1/AIDS pandemic continues to have a disproportionate impact on vulnerable and under-served communities in the USA and globally. In the USA, minority communities that have relatively ...read more
Lymphomas in People Living with HIV (PLWH)
In the era of combined antiretroviral therapy (cART), the incidence of lymphoma among people living with HIV (PLWH) surpassed Kaposi's sarcoma in 2011, becoming the most common AIDS-defining malignancy. The annual incidence rate ranges approximately from 100 to 300 per 100,000 individuals with HIV infection as the population denominator, which ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Editorial [Hot Topic: New Developments in Drug and Vaccine Discoveries (Executive Editor: Aldar S. Bourinbaiar)]
Current Pharmaceutical Design Antimicrobial, Antitumor and Side Effects Assessment of a Newly Synthesized Tamoxifen Analog
Current Topics in Medicinal Chemistry Targeting TNF-Alpha in HIV-1 Infection
Current Drug Targets Malononitrile as a Key Reagent in Multicomponent Reactions for the Synthesis of Pharmaceutically Important Pyridines
Current Organic Chemistry Subject Index To Volume 7
Current Pharmaceutical Design Membrane Binding Mechanism of Yeast Mitochondrial Peripheral Membrane Protzein TIM44
Protein & Peptide Letters Mucosal Adjuvants
Current HIV Research Naturally-occurring Dimers of Flavonoids as Anticarcinogens
Anti-Cancer Agents in Medicinal Chemistry Primary Isolated Mediastinal Abscess Masquerading as Mediastinal Mass- A Needle did the Trick
Current Respiratory Medicine Reviews A Review of the Treatment of Psoriasis with Infliximab
Reviews on Recent Clinical Trials Identification and in silico Characterization of Semenogelin II Protein in Semen- A Marker for Diagnosis of male Infertility
Current Proteomics The Application of Cell-Penetrating-Peptides in Antibacterial Agents
Current Medicinal Chemistry Recent Developments in the Synthesis of Substituted Purine Nucleosides and Nucleotides
Current Organic Chemistry Bacterial Zinc Proteases and their Inhibition
Current Enzyme Inhibition Immunomodulatory Drugs as a Therapy for Multiple Myeloma
Current Pharmaceutical Biotechnology Function Prediction of Hypothetical Proteins Without Sequence Similarity to Proteins of Known Function (SUPPLEMENTARY MATERIALS)
Protein & Peptide Letters Nanochemistry-Based Immunotherapy for HIV-1
Current Medicinal Chemistry Liposomes as Potential Carrier System for Targeted Delivery of Polyene Antibiotics
Recent Patents on Inflammation & Allergy Drug Discovery Resistant TB: Newer Drugs and Community Approach
Recent Patents on Anti-Infective Drug Discovery COVID-19/Any Respiratory Pandemic- What a Radiology Resident Must Know and Report
Current Medical Imaging